New Date Capture and Reporting Service Network has been Created for Clinical Trials in Japan

According to this article in Outsourcing-Pharma.com PHT, which is a US ePro specialist, has teamed up with CRO CMIC to create a data capture and reporting service network for clinical trials in Japan.

The service will include PHT's patient reporting technologies to biopharmaceutical clients running trials in Japan, and CRO CMIC will provide clinical trials services to both industry drug sponsors and clinical trials sites. They will also supply development, trial-scale production and marketing services through its network to neighboring countries like Korea, China, Taiwan, and Singapore.

The Use of Bid Grids for Selecting a CRO as a Partner

This article in Applied Clinical Trials details how most companies use bid grids in order to establish both an overall outsourcing budget and the expected budget for individual major outsourced studies. So who's using bid grids?

According to the article 90% of the American participants of a suvey conducted by the University of Health Sciences and TTC reported using a common bid grid, in contrast to just over half, 52% percent of locations worldwide. 81% of larger pharma companies reported using a common bid grid as opposed 49% of participants from smaller companies that use a common bid grid.

Do you think bid grids are useful?

Key Findings on CRO Industry

Over at FierceBiotech they've recently summarized some key findings from the Top 10 Contract Research Organizations, which is a report published by Business Insights that examines the competitive landscape of the global CRO industry. Here are some of the issues they've uncovered:

• The CRO market will grow at an annual rate of about 14% over the course of the next 3 years.
• Quintiles leads the CRO market this past year, but the 10 major CROs accounts for 56.1% of the market. There are over 1,100 players in the industry.
• In an attempt to expand services and offerings, it has led to increased alliances, joint-ventures, and other partnership deals.
• Covance is the 2nd largest CRO only trailing Quintiles
• Biomarkers will become an important part of clinical research after the FDA has recommended their usage
  

ICON teaming up with MedAvante

To improve clinical trials dealing with central nervous systems, ICON has teamed up with MedAvante. This alliance will allow a better look into the trials, as they are often difficult to monitor. It will also allow for the two groups to offer new services to drug companies developing drugs to treat central nervous system disorders. For the full story, read here.

Partnerships with CROs now has a Twitter! Follow us here.